Nanalysis Scientific (CVE:NSCI) Shares Up 7.1% – Should You Buy?

Shares of Nanalysis Scientific Corp. (CVE:NSCIGet Free Report) were up 7.1% during trading on Tuesday . The company traded as high as C$0.30 and last traded at C$0.30. Approximately 10,500 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 59,890 shares. The stock had previously closed at C$0.28.

Nanalysis Scientific Stock Up 7.1 %

The business’s 50-day moving average is C$0.31 and its two-hundred day moving average is C$0.34. The firm has a market capitalization of C$33.92 million, a price-to-earnings ratio of -2.50 and a beta of 0.72. The company has a debt-to-equity ratio of 71.72, a quick ratio of 1.11 and a current ratio of 1.42.

Nanalysis Scientific Company Profile

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.

Further Reading

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.